Buchanan Ingersoll & Rooney

Buchanan Ingersoll & Rooney PC is an American national law firm founded in 1850 with over 450 attorneys across 17 offices. It has deep expertise in healthcare and life sciences industries among others, providing legal counsel on regulatory compliance, mergers and acquisitions, government relations, litigation including product liability cases related to pharmaceuticals and biotechnology products. The firm represents hospitals, health systems, biotechnology companies like Kolon TissueGene in manufacturing disputes and government investigations. It also advises pharmacies on regulatory audits and reimbursement issues.

The firm's healthcare practice includes handling complex clinical integrations/M&A transactions for hospital systems; advising on Medicare disputes; data security/HIPAA compliance; physician compensation plans; fraud/abuse investigations; joint ventures with medical device/pharmaceutical companies; pharmacy benefit management strategies; intellectual property litigation support for biotech patents.

While deeply involved with clients in the life sciences sector legally, the entity itself does not develop or commercialize therapeutic products.